Your browser doesn't support javascript.
loading
A semi-supervised learning framework for quantitative structure-activity regression modelling.
Watson, Oliver; Cortes-Ciriano, Isidro; Watson, James A.
Afiliação
  • Watson O; Evariste Technologies Ltd, Goring on Thames RG8 9AL, UK.
  • Cortes-Ciriano I; Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Watson JA; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX1 2JD, UK.
Bioinformatics ; 37(3): 342-350, 2021 04 20.
Article em En | MEDLINE | ID: mdl-32777821
MOTIVATION: Quantitative structure-activity relationship (QSAR) methods are increasingly used in assisting the process of preclinical, small molecule drug discovery. Regression models are trained on data consisting of a finite-dimensional representation of molecular structures and their corresponding target-specific activities. These supervised learning models can then be used to predict the activity of previously unmeasured novel compounds. RESULTS: This work provides methods that solve three problems in QSAR modelling: (i) a method for comparing the information content between finite-dimensional representations of molecular structures (fingerprints) with respect to the target of interest, (ii) a method that quantifies how the accuracy of the model prediction degrades as a function of the distance between the testing and training data and (iii) a method to adjust for screening dependent selection bias inherent in many training datasets. For example, in the most extreme cases, only compounds which pass an activity-dependent screening threshold are reported. A semi-supervised learning framework combines (ii) and (iii) and can make predictions, which take into account the similarity of the testing compounds to those in the training data and adjust for the reporting selection bias. We illustrate the three methods using publicly available structure-activity data for a large set of compounds reported by GlaxoSmithKline (the Tres Cantos AntiMalarial Set, TCAMS) to inhibit asexual in vitro Plasmodium falciparum growth. AVAILABILITYAND IMPLEMENTATION: https://github.com/owatson/PenalizedPrediction. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Antimaláricos Tipo de estudo: Prognostic_studies Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Antimaláricos Tipo de estudo: Prognostic_studies Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2021 Tipo de documento: Article